TY - JOUR
T1 - Escherichia coli expression, purification, and refolding of human folate receptor α (hFRα) and β (hFRβ)
AU - Dharmatti, Roopa
AU - Miyatake, Hideyuki
AU - Zhang, Chen
AU - Ren, Xueli
AU - Yumoto, Akiko
AU - Kiga, Daisuke
AU - Yamamura, Masayuki
AU - Ito, Yoshihiro
N1 - Funding Information:
This project was funded by the Incentive Research Program in RIKEN ( FY2016 , HM) and JSPS-Turkey ( I2016652 , YI). RD was supported by the International Program Associate in RIKEN (IPA number: 151022 ). We thank Primetech Corp. for helping us to analyze the BLItz data.
Publisher Copyright:
© 2018
PY - 2018/9
Y1 - 2018/9
N2 - Human folate receptors (hFRα and hFRβ) are membrane proteins anchored to the cell surface by glycosylphosphatidylinositol. They play an important role in cell growth by taking up folate for de novo synthesis of purines and methylation of DNA, lipids, and proteins. Thus, controlling folate uptake through hFRs may lead to the development of anti-cancer drugs. Development of hFRs-targeting drug requires a large amount of hFRs. However, it is difficult to prepare active forms of hFRs from prokaryotic cells because of their high content of cysteine residues that form disulfide bonds. Here, we prepared active forms of hFRα and hFRβ from inclusion bodies of Escherichia coli. The crucial steps in our preparation were intensive washing of the inclusion bodies to remove impurities derived from E. coli and gradual dropping of solubilized hFRs into refolding buffers to correctly reform disulfide bonds. The binding activity of prepared hFRs to folate was confirmed by biolayer interferometry measurements. Finally, we successfully prepared the active form of 2.52 mg hFRα and 2.4 mg hFRβ from 10 g of E. coli cell bodies.
AB - Human folate receptors (hFRα and hFRβ) are membrane proteins anchored to the cell surface by glycosylphosphatidylinositol. They play an important role in cell growth by taking up folate for de novo synthesis of purines and methylation of DNA, lipids, and proteins. Thus, controlling folate uptake through hFRs may lead to the development of anti-cancer drugs. Development of hFRs-targeting drug requires a large amount of hFRs. However, it is difficult to prepare active forms of hFRs from prokaryotic cells because of their high content of cysteine residues that form disulfide bonds. Here, we prepared active forms of hFRα and hFRβ from inclusion bodies of Escherichia coli. The crucial steps in our preparation were intensive washing of the inclusion bodies to remove impurities derived from E. coli and gradual dropping of solubilized hFRs into refolding buffers to correctly reform disulfide bonds. The binding activity of prepared hFRs to folate was confirmed by biolayer interferometry measurements. Finally, we successfully prepared the active form of 2.52 mg hFRα and 2.4 mg hFRβ from 10 g of E. coli cell bodies.
KW - Bio-layer interferometry (BLI)
KW - Escherichia coli expression
KW - Folate
KW - Gradual dropping refolding
KW - Human folate receptor α (hFRα)
KW - Human folate receptor β (hFRβ)
KW - Immobilized metal affinity chromatography (IMAC)
KW - Inclusion body
KW - Intensive washing of inclusion body
KW - Solubilization
UR - http://www.scopus.com/inward/record.url?scp=85045708315&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045708315&partnerID=8YFLogxK
U2 - 10.1016/j.pep.2018.04.006
DO - 10.1016/j.pep.2018.04.006
M3 - Article
C2 - 29654824
AN - SCOPUS:85045708315
SN - 1046-5928
VL - 149
SP - 17
EP - 22
JO - Protein Expression and Purification
JF - Protein Expression and Purification
ER -